Association between biomass formation and the prognosis of infective endocarditis due to Staphylococcus aureus

Enferm Infecc Microbiol Clin (Engl Ed). 2020 Jun-Jul;38(6):263-266. doi: 10.1016/j.eimc.2019.10.008. Epub 2019 Dec 2.
[Article in English, Spanish]

Abstract

Introduction: The aim of this study was to evaluate the association between biomass formation and the clinical characteristics and prognosis of Staphylococcus aureus infective endocarditis (IE).

Methods: We prospectively studied 209 S. aureus strains causing IE. Biomass formation was examined using the crystal violet assay and quantified spectrophotometrically. The average (SD) optical density of the biomass was compared for each clinical, microbiological (methicillin-resistance, vancomycin MIC≥1.5μg/ml) and molecular (clonal complex, agr type and agr dysfunction) variable according to their presence or absence. The primary clinical endpoints studied were in-hospital death, severe sepsis, persistent bacteraemia, symptomatic peripheral embolisms and prosthetic valve IE.

Results: Mean age was 66.1 years, 61.5% of patients were male and the median age-adjusted Charlson comorbidity index was 5 points (IQR 3-8). In-hospital mortality was 37.3%. Strains belonging to CC5 and CC22 had optical biomass densities [mean (SD) 1.573 (1.14) vs 0.942 (0.98) p<0.001 and 1.720 (0.94) vs 1.028 (1.04) p=0.001, respectively]. Strains belonging to CC5 and CC22 had significantly higher optical biomass densities [1.369 (1.18) vs 0.920 (0.93) p=0.008]. No statistically significant differences were found in the clinical endpoints studied.

Conclusions: High biomass production was associated with CC5 and CC22 but not with higher hospital mortality, septic complications, type of endocarditis, methicillin-resistance, elevated vancomycin MIC or agr dysfunction.

Keywords: Biofilm; Biomasa; Biomass; Biopelícula; Densidad óptica; Endocarditis infecciosa; Infective endocarditis; Optical density; Prognosis; Pronóstico; Staphylococcus aureus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Bacteremia
  • Endocarditis, Bacterial / diagnosis*
  • Female
  • Hospital Mortality
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Prognosis
  • Sepsis
  • Staphylococcal Infections / complications*
  • Staphylococcus aureus

Substances

  • Anti-Bacterial Agents